Study guide

10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations

MRCP UK

Track your progress as you read

Finished sections get a check mark.

1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy

1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique

2 Clinical Sciences: Cellular, Genetic & Molecular Medicine

2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders

3 Clinical Sciences: Anatomy, Physiology & Immunology

3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions

4 Clinical Sciences: Statistics, Epidemiology & Trial Design

4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification

5 Clinical Pharmacology, Therapeutics & Toxicology

5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols

6 Cardiology: Coronary Artery Disease & Heart Failure

6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation

7 Cardiology: Arrhythmias, Valvular & Pericardial Disease

7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases

8 Respiratory Medicine: Airway & Parenchymal Lung Disease

8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis

9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders

9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing

10 Gastroenterology: Luminal Gastrointestinal Disease

10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia

11 Gastroenterology: Liver, Biliary & Pancreatic Disease

11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis

12 Endocrinology & Diabetes: Diabetes & Thyroid

12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules

13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium

13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease

14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease

14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases

15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance

15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis

16 Neurology: Cerebrovascular, Headache & Demyelinating Disease

16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases

17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease

17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders

18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease

18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies

19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy

19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease

20 Infectious Diseases & Tropical Medicine

20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites

21 Haematology: Anaemias & Red Cell Disorders

21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease

22 Haematology: Malignancy, Coagulation & Transfusion Medicine

22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions

23 Psychiatry in General Medicine

23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law

24 Geriatric Medicine

24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers

25 Dermatology

25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy

26 Oncology & Palliative Medicine

26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control

27 Medical Ophthalmology

27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease

10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations

Key Takeaways Explain This Topic AI

Crohn's disease shows skip lesions, transmural inflammation and non-caseating granulomas; ulcerative colitis is continuous, mucosal and extends proximally from the rectum.

Pyoderma gangrenosum and primary sclerosing cholangitis run independently of bowel disease activity, whereas erythema nodosum and episcleritis parallel it.

Toxic megacolon is defined by transverse colonic dilatation above 6 cm with systemic toxicity and requires urgent surgical review.

Last updated: September 2026

Inflammatory bowel disease (IBD) and small bowel malabsorptive disorders are frequently tested on MRCP(UK) Part 1. Candidates are expected to differentiate Crohn's disease from ulcerative colitis across clinical, endoscopic, and histological domains, understand the complex pharmacology of induction and maintenance agents, execute emergency protocols for acute severe ulcerative colitis, and master the diagnosis and systemic complications of coeliac disease.

1. Crohn's Disease vs Ulcerative Colitis

Inflammatory bowel disease displays a bimodal age incidence, peaking between 15–30 years with a second smaller peak between 60–80 years. Environmental factors exert divergent influences: cigarette smoking worsens Crohn's disease (increasing flare frequency, stricture formation, and surgical resection rates), whereas smoking exerts a paradoxically protective effect in ulcerative colitis (non-smokers and ex-smokers are at highest risk of developing UC, and smoking cessation frequently precipitates a severe flare). Appendicectomy performed in early life is protective against ulcerative colitis.

Comparative Clinical, Endoscopic, Radiological & Histological Features

Domain Crohn's Disease (CD) Ulcerative Colitis (UC)

Anatomical Distribution Any part of GI tract from mouth to anus; terminal ileum and proximal colon most common (~50%); rectal sparing in ~50% Confined to colon and rectum ; begins in rectum (proctitis in 95%) and extends proximally in an uninterrupted, continuous manner

Pattern of Involvement Discontinuous ("skip lesions") with intervening areas of normal mucosa Continuous and symmetrical ; no skip areas (except occasional "backwash ileitis" or caecal patch)

Depth of Inflammation Transmural (involves mucosa, submucosa, muscularis propria, and serosa) Mucosal and submucosal only ; muscularis propria and serosa are spared (except in toxic megacolon)

Macroscopic / Endoscopic Findings Deep, longitudinal, serpiginous "knife-like" or "bear-claw" ulcers ; "cobblestone" mucosa ; strictures; serosal "creeping fat" Diffuse mucosal erythema, granular appearance, extreme contact friability, superficial bleeding ulcers, inflammatory pseudopolyps

Histopathological Hallmarks Non-caseating epithelioid granulomas (~50%, pathognomonic); transmural lymphoid aggregates; fissuring ulcers; knife-like clefts Crypt abscesses (neutrophilic collections within crypt lumens); crypt architectural distortion and branching; goblet cell depletion; no granulomas

Radiological Findings Barium follow-through / MRE: "String sign of Kantor" (terminal ileal narrowing/stricture); asymmetric bowel wall thickening; internal fistulae Barium enema / CT: Loss of normal colonic haustrations ( "lead-pipe" or "hose-pipe" colon); fine mucosal spiculation ("collar-button" ulcers)

Cardinal Complications Fibrostenotic strictures , bowel obstruction, fistulae (enterocutaneous, enterovesical, enterocolic), perianal disease, abscesses, gallstones Toxic megacolon (transverse diameter >6 cm), colonic perforation, life-threatening lower GI haemorrhage, primary sclerosing cholangitis , colorectal cancer

Perianal Disease Frequent (~30–50%) : Complex branching perianal fistulae, deep fissures, indolent perianal skin tags, ischiorectal abscesses Rare; limited to simple, superficial fissures or excoriations secondary to severe diarrhoea

Serological Biomarkers Anti- Saccharomyces cerevisiae antibodies ( ASCA positive in ~60%) Perinuclear antineutrophil cytoplasmic antibodies ( p-ANCA positive in ~65%)

2. Extraintestinal Manifestations (EIMs) of IBD

Extraintestinal manifestations occur in up to 40% of patients with IBD. For the MRCP examination, these must be categorized by whether their clinical activity mirrors luminal gastrointestinal inflammation:

A. Manifestations that Parallel Luminal Bowel Disease Activity

These complications flare in tandem with active intestinal inflammation and characteristically resolve once luminal bowel disease is brought into remission (or surgically resected in UC):

Peripheral Arthropathy (Type 1): Pauciarticular (<5 joints involved), asymmetric, affecting large weight-bearing lower limb joints (knees, ankles, hips). Non-deforming, non-erosive, and self-limiting; parallels bowel activity closely.

Erythema Nodosum: Tender, hot, erythematous subcutaneous nodules classically located over the anterior pretibial shins. Present in ~15% of CD and ~10% of UC during active flares.

Episcleritis: Injected, fiery-red vascular engorgement of the superficial episcleral plexus. Painless or mildly aching; visual acuity is completely preserved; vessels blanch upon topical phenylephrine application. Activity mirrors intestinal flares.

Aphthous Stomatitis: Painful oral mucosal ulcerations that appear during active exacerbations.

B. Manifestations Independent of Luminal Bowel Disease Activity

These complications pursue an autonomous clinical course and do NOT correlate with intestinal disease activity ; they may antedate bowel symptoms, persist during deep endoscopic remission, and progress even after total proctocolectomy:

Axial Spondyloarthropathy & Ankylosing Spondylitis: Strongly associated with the HLA-B27 allele (present in 50–70% of IBD patients with axial disease). Manifests as inflammatory back pain (worse at rest, improving with physical exercise, nocturnal wakening) and progressive bilateral sacroiliitis leading to syndesmophyte formation and "bamboo spine". Runs an entirely autonomous course.

Peripheral Arthropathy (Type 2): Polyarticular (>=5 joints), symmetric, predilection for small joints of the hands (metacarpophalangeal and proximal interphalangeal joints). Pursues a chronic course lasting years, independent of bowel activity.

Pyoderma Gangrenosum: Debilitating, painful, non-infectious inflammatory dermatosis. Initiates as a pustule or erythematous nodule that rapidly breaks down into an expanding, necrotic ulcer with violaceous, undermined, purplish borders and a purulent cribriform base. Classically exhibits pathergy —the rapid induction or worsening of ulceration following minor mechanical trauma, venepuncture, or biopsy. Surgical debridement is strictly contraindicated as it exacerbates tissue necrosis. Treatment requires systemic high-dose corticosteroids, oral ciclosporin, or anti-TNF therapy (infliximab). Runs a course completely independent of bowel activity.

Primary Sclerosing Cholangitis (PSC): Chronic fibrosing inflammatory obliteration of intrahepatic and extrahepatic bile ducts. Approximately 70–80% of patients with PSC have underlying IBD (predominantly ulcerative colitis); conversely, ~5% of patients with UC develop PSC. Characterized by elevated alkaline phosphatase and "beaded" strictures on MRCP. Runs a totally independent course; proctocolectomy does not arrest hepatic progression . Concurrently elevates the lifetime risk of cholangiocarcinoma and accelerates colorectal carcinogenesis, mandating annual screening colonoscopy with chromoendoscopy from the time of PSC diagnosis.

Anterior Uveitis (Iritis): Severe ocular pain, marked photophobia, blurred vision, ciliary flush, and sluggish pupil. Slit-lamp examination demonstrates inflammatory cells and protein flare in the anterior chamber. Sight-threatening ophthalmic emergency requiring immediate topical corticosteroids and cycloplegic-mydriatic agents to prevent posterior synechiae formation.

Metabolic & Vascular Sequelae:

Nephrolithiasis: Calcium oxalate stones in Crohn's ileal disease (unabsorbed fatty acids bind luminal calcium, leaving free oxalate to be hyperabsorbed in the colon: "enteric hyperoxaluria"). Uric acid stones in ileostomies due to chronic dehydration and acidic urine.

Venous Thromboembolism (VTE): 3- to 4-fold elevated risk of deep vein thrombosis and pulmonary embolism during active flares driven by acute phase reactants, elevated factor VIII, and hyperfibrinogenaemia.